Approval · Notice of Compliance 2091 · 1999
PMS-FLUVOXAMINE: Notice of Compliance 2091
Issued August 19, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2091
- Date
- August 19, 1999
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antidepressant/antiobsessional
- Canadian reference product
- LUVOX (Solvay Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-FLUVOXAMINE | 02240682 | Cancelled Post Market |
| PMS-FLUVOXAMINE | 02240683 | Cancelled Post Market |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB